
Edagen 1.5mg Injection
Marketer
Innovative Pharmaceuticals
Salt Composition
Edaravone (1.5mg)
Overview Edagen 1.5mg Injection
For amyotrophic lateral sclerosis (ALS), a debilitating neuromuscular disorder, Edagen 1.5mg Injection offers therapeutic benefit by slowing disease progression. This antioxidant medication works by reducing nerve cell damage, administered intravenously by a healthcare provider only. Parenteral administration is necessary when oral ingestion is infeasible. Always follow your physician's prescribed dosage and regimen; if a dose is missed, administer it immediately upon recollection. Commonly reported side effects include cephalgia, ecchymosis, and gait abnormalities. Localized injection site reactions, such as erythema, edema, or discomfort, may also occur, typically resolving spontaneously. Persistent or bothersome side effects warrant medical consultation. Seek immediate medical attention should allergic responses such as facial, lip, or tongue swelling, or pruritus develop.
Uses of Edagen 1.5mg Injection
Lou Gehrig's disease
Major Benefits of Edagen 1.5mg Injection:
Administering this medication will be done by your physician or their qualified staff; self-medication is strictly prohibited.
Common Side effects of Edagen 1.5mg Injection:
- Bruise
- Walking difficulties
- Headache
- Injection site reactions (pain, swelling, redness)
How to use Edagen 1.5mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
How Edagen 1.5mg Injection works:
Edagen 1.5mg Injection offers antioxidant, neuroprotective, and nootropic benefits. Its mechanism involves mitigating nerve damage from free radical attack, thus delaying ALS symptom onset. This effect is achieved by restoring equilibrium between antioxidants and free radicals, reducing oxidative stress within the brain.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption with Edagen 1.5mg Injection may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Edagen 1.5mg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on Edagen 1.5mg Injection use while breastfeeding is absent. Seek medical advice from your physician.
DrivingCONSULT YOUR DOCTOR
The effect of Edagen 1.5mg Injection on driving ability is undetermined. Refrain from driving if you exhibit any symptoms impairing concentration or reaction time.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Edagen 1.5mg Injection to individuals with renal impairment. Seek medical advice from your physician.
LiverCAUTION
The use of Edagen 1.5mg Injection requires careful consideration in individuals with severe hepatic impairment; dosage modification may be necessary. Physician consultation is advised. Data regarding Edagen 1.5mg Injection administration in such patients is limited. Dosage alteration is not suggested for those with mild to moderate liver dysfunction.
What if you forget to take Edagen 1.5mg Injection :
NA
Facts to Know About Edagen 1.5mg Injection
| Label | Value |
|---|---|
| Chemical Category | Pyrazolone Derivatives |
| Developing Habits | No. |
| Treatment Category | Neuroscience Central Nervous System |
| Action Class | Cognitive enhancer |
